Keynote 789 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keynote 789. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keynote 789 Today - Breaking & Trending Today

Subgroup Observations From Missed KEYNOTE-789 Data in NSCLC Provide Insight for the Future

James Chih-Hsin Yang, MD, PhD, discusses the implications of the phase 3 KEYNOTE-789 trial and what directions investigators can examine in the future to help fill the unmet need for patients with TKI-resistant, EGFR-mutated metastatic non–small cell lung cancer. ....

James Chih Hsin Yang , Department Of Oncology , Institute Of Oncology , National Taiwan University , National Taiwan University Hospital , Graduate Institute , East Asian , Keynote 789 , Non Small Cell Lung Cancer , Lung Cancer , Egfr Mutated Nsclc , Asco Annual Meeting ,

Key Trials at ASCO 2023 Highlight Role of Perioperative Treatment Approaches in NSCLC

Jarushka Naidoo, MBBCh, discussed the clinical significance of datasets from several phase 3 trials presented at the 2023 ASCO Annual Meeting, including ADAURA, KEYNOTE-617, CheckMate 816, and CheckMate 9LA trials. ....

Jarushka Naidoo , Heather Wakelee , Stanford Health , European Medicines Agency , Royal College Of Surgeons Ireland Cancer Centre , News Network , Royal College , Surgeons Ireland Cancer Centre , Beaumont Hospital , Treating Field , Amivantamab Plus Lazertinib , Patients With Egfr Mutated Non Small Cell Lung Cancer , Checkmate 816 , Keynote 617 , Checkmate 9la , Artemide 01 , Keynote 789 ,